The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors

Clinical and Experimental Immunology

Volumn 138, Issue 2, 2004, Pages 312-316

  Stebbing, J ^a   Bower, M ^a   Gazzard, B ^a   Wildfire, A ^a   Pandha, H ^b   Dalgleish, A ^b   Spicer, James ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

CD91; Skin cancer melanoma

Indexed keywords

CD8 ANTIGEN; CYTOKINE; HEAT SHOCK PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INTERNALIZATION; MELANOMA; METASTASIS; MONOCYTE; PRIORITY JOURNAL; SKIN CANCER; TH1 CELL; TH2 CELL; TUMOR IMMUNOLOGY;

ADULT; AGED; ANTIGENS, CD; CYTOKINES; DISEASE PROGRESSION; HEAT-SHOCK PROTEINS; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTE SUBSETS; MELANOMA; MIDDLE AGED; MONOCYTES; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SKIN NEOPLASMS; TH1 CELLS; TH2 CELLS; UP-REGULATION;

EID: 8144222926     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02619.x     Document Type: Article

References (29)

1. Whelan M, Whelan J, Russell N et al. Cancer immunotherapy: an embarrassment of riches? Drug Discov Today 2003; 8:253-8.
2. Stebbing J, Gazzard B, Kim L et al. The heat shock protein receptor CD91 is upregulated in monocytes of HIV-1-infected 'true' long-term non-progressors. Blood 2003; 101:4000-4.
3. Stebbing J, Gazzard B, Portsmouth S et al. Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. Blood 2003; 102:1806-14.
4. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immunol 2000; 1:151-5.
5. Basu S, Binder RJ, Ramalingam T et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14:303-13.
6. Nassar T, Akkawi S, Bar-Shavit R et al. Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Blood 2002; 100:4026-32.
7. Zhang L, Yu W, He T et al. Contribution of human alpha-defensin-1, -2 and -3 to the anti-HIV-1 activity of CDS antiviral factor. Science 2002; 298:995-1000.
8. Musey L, Hughes J, Schacker T et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997; 337:1267-74.
9. Migueles SA, Laborico AC, Shupert WL et al. HIV-specific CD8(+) T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-8.
10. Spicer J, Gore ME. Malignant melanoma. In: Price P, Sikora K, eds. Treatment of cancer. London: Arnold, 2002:831-50.
11. Stebbing J, Bower M. What can oncologists learn from HIV? Lancet Oncol 2003; 4:438-45.
12. Stebbing J, Benson C, Eisen T et al. The treatment of advanced renal cell cancer with high-dose oral thalidomide. Br J Cancer 2001; 85:953-8.
13. Kanetsky PA, Holmes R, Walker A et al. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 2001; 10:509-13.
14. Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94:894-903.
15. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene 2003; 22:3042-52.
16. Maltseva N, Zorina R, Mingaljev N et al. Tissue distributiion of rat macroglobulins in tumour-bearing rats. Int J Exp Pathol 1999; 80:105-8.
17. Hunter N, Weston K, Bowern N. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin. Immunol 1991; 73:58-63.
18. Banerjee PP, Vinay DS, Mathew A et al. Evidence that glycoprotein 96 (B2), a stress protein, functions as a Th2-specific costimulatory molecule. J Immunol 2002; 169:3507-18.
19. Moroi Y, Mayhew M, Trcka J et al. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc Natl Acad Sci USA, 2000; 97:3485-90.
20. Ishii T, Udono H, Yamano T et al. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol 1999; 162:1303-9.
21. Castellino F, Boucher PE, Eichelberg K et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 2000; 191:1957-64.
22. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2:185-94.
23. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20:395-425.
24. Mocellin S, Provenzano M, Lise M et al. Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor-alpha to patients with soft tissue limb sarcoma. Int J Cancer 2003; 107:317-22.
25. Eggermont AM, de Wilt JH, ten Hagen TL. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 2003; 4:429-37.
26. Neumark E, Sagi-Assif O, Shalmon B et al. Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors. Int J Cancer 2003; 106:879-86.
27. Delneste Y, Magistrelli G, Gauchat J et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002; 17:353-62.
28. Lipsker D, Ziylan U, Spehner D et al. Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells. Eur J Immunol 2002; 32:322-32.
29. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-18.